Boai NKY Pharmaceuticals Ltd Cash Flow-to-Debt Ratio
Boai NKY Pharmaceuticals Ltd cash flow-to-debt ratio. Boai NKY Pharmaceuticals Ltd (300109) has a Cash Flow-to-Debt Ratio of 0.25x as of September 2025, meaning its operating cash flow of CN¥139.46 Million could theoretically repay 0% of its total liabilities (CN¥552.11 Million) in one year. Check Boai NKY Pharmaceuticals Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Boai NKY Pharmaceuticals Ltd (2007–2025)
Cash flow-to-debt ratio of Boai NKY Pharmaceuticals Ltd from 2007 to 2025. Historical debt coverage capacity for Boai NKY Pharmaceuticals Ltd across 19 annual periods. Check Boai NKY Pharmaceuticals Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Boai NKY Pharmaceuticals Ltd Cash Flow-to-Debt Ratio by Year (2007–2025)
Boai NKY Pharmaceuticals Ltd cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Boai NKY Pharmaceuticals Ltd. For the full cash flow conversion analysis, see Boai NKY Pharmaceuticals Ltd (300109) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.47x | CN¥338.11 Million | CN¥713.16 Million | ▲ +41.5% |
| 2024 | 0.33x | CN¥256.03 Million | CN¥764.37 Million | ▼ -65.7% |
| 2023 | 0.98x | CN¥488.25 Million | CN¥499.66 Million | ▲ +131.4% |
| 2022 | 0.42x | CN¥251.77 Million | CN¥596.29 Million | ▲ +473.2% |
| 2021 | 0.07x | CN¥43.44 Million | CN¥589.76 Million | ▼ -70.5% |
| 2020 | 0.25x | CN¥266.87 Million | CN¥1.07 Billion | ▲ +258.6% |
| 2019 | 0.07x | CN¥79.64 Million | CN¥1.14 Billion | ▲ +46.4% |
| 2018 | 0.05x | CN¥48.81 Million | CN¥1.03 Billion | ▼ -34.0% |
| 2017 | 0.07x | CN¥47.28 Million | CN¥656.22 Million | ▼ -94.7% |
| 2016 | 1.37x | CN¥114.14 Million | CN¥83.32 Million | ▲ +56.2% |
| 2015 | 0.88x | CN¥64.12 Million | CN¥73.11 Million | ▲ +40.0% |
| 2014 | 0.63x | CN¥46.60 Million | CN¥74.38 Million | ▲ +23.2% |
| 2013 | 0.51x | CN¥23.17 Million | CN¥45.58 Million | ▲ +12.8% |
| 2012 | 0.45x | CN¥20.65 Million | CN¥45.81 Million | ▲ +343.7% |
| 2011 | 0.10x | CN¥3.94 Million | CN¥38.80 Million | ▼ -75.1% |
| 2010 | 0.41x | CN¥10.05 Million | CN¥24.60 Million | ▼ -30.4% |
| 2009 | 0.59x | CN¥28.57 Million | CN¥48.66 Million | ▲ +781.9% |
| 2008 | -0.09x | CN¥-4.09 Million | CN¥47.52 Million | ▼ -144.0% |
| 2007 | 0.20x | CN¥9.56 Million | CN¥48.84 Million | — |